Enlarged extracellular vesicles are a negative prognostic factor in patients undergoing TACE for primary or secondary liver cancer-a case series.
David SchölerMirco CastoldiMarkus S JördensMax Schulze-HagenChristiane KuhlVerena KeitelTom LueddeChristoph RoderburgSven H LoosenPublished in: PloS one (2021)
Sizes (but not concentrations) of EVs represent a novel prognostic marker in patients receiving TACE for primary and secondary hepatic malignancies since patients with enlarged EVs display a significantly impaired prognosis after TACE.
Keyphrases